Y Intercept (Hong Kong) LTD Sangamo Therapeutics, Inc Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $267,876 - $483,666	744,102 New	744,102 $267,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $109,434 - $171,546	98,590 New	98,590 $128,000
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $54,222 - $99,245	-19,575 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$4.27 - $6.39 $83,585 - $125,084	19,575 New	19,575 $95,000

114

56.3M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $337M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.